Serologicals, LINCO, NIST | GenomeWeb

Serologicals, LINCO, NIST

Premium

Serologicals to Acquire LINCO for $75M to Expand Multiplexing Products Portfolio

Serologicals announced this week that it has made an agreement to acquire LINCO, a life sciences company that focuses on supplying research assays and test kits for the Luminex-based multiplexing platform and other immunoassays.

Under terms of the agreement, Serologicals will pay $64.5 million in cash for the LINCO business, which has 109 employees, plus an additional $10.3 million for the land and buildings currently occupied by LINCO in St. Louis, Mo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.